Asthma 17q21 polymorphism associates with decreased risk of COVID-19 in children.

TitleAsthma 17q21 polymorphism associates with decreased risk of COVID-19 in children.
Publication TypeJournal Article
Year of Publication2022
AuthorsGourari I, Gomi R, Young M, Jordan G, Liongson M, Heras A, Gerber LM, Thomas C, Tsirilakis K, Ono J, Narula P, Ketas T, Moore JP, Worgall S, Permaul P
JournalPediatr Pulmonol
Volume57
Issue11
Pagination2855-2860
Date Published2022 Nov
ISSN1099-0496
KeywordsAsthma, Child, COVID-19, Genetic Predisposition to Disease, Humans, Risk Factors
DOI10.1002/ppul.26091
Alternate JournalPediatr Pulmonol
PubMed ID35932217
PubMed Central IDPMC9538222
Grant ListK23 AI123517 / AI / NIAID NIH HHS / United States
R01 AI036082 / AI / NIAID NIH HHS / United States
UL1 TR002384 / TR / NCATS NIH HHS / United States
P01 AI110657 / AI / NIAID NIH HHS / United States
UL1 TR000457 / TR / NCATS NIH HHS / United States
L40 AI113791 / AI / NIAID NIH HHS / United States
KL2 TR002385 / TR / NCATS NIH HHS / United States

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587